StratDeck

Two stocks in Drug Manufacturers - General

AbbVie vs Bristol-Myers Squibb: profit, growth, debt and price compared

Bristol-Myers Squibb is stronger on 3 of 6 figures: profit margin, price for its expected profit and dividend. AbbVie is stronger on 2: sales growth and price trend.

Figures as of 18 November 2026SEC EDGARYahoo Finance
Explore AbbVie's storyWhere next ↓

Save both stocks to your watchlist and revisit their latest fundamentals.

AbbVie and Bristol-Myers Squibb side by side
AbbVieABBVBristol-Myers SquibbBMY
Net margin15.7%Stronger: 18.5%
Revenue growth, past yearStronger: +10.32%+6.93%
Debt to equity—191.5%
Forward P/E17.6×Stronger: 8.9×
Dividend yield2.42%Stronger: 4.23%
AnalystsBuy · 26Buy · 24
From its 200-day averageStronger: +15.5%+1.2%

Share price over the past year

  • AbbVie+22.3%
  • Bristol-Myers Squibb+26.6%

18 Nov 202518 Nov 2026

AbbVie or Bristol-Myers Squibb: which is stronger?

  • BMY

    Which is more profitable?

    Bristol-Myers Squibb keeps more of each sale as profit: 18.5% against 15.7%.

  • ABBV

    Which is growing its sales faster?

    AbbVie is growing its sales faster: +10.32% over the past year, against +6.93%.

  • BMY

    Which costs less for the profit it is expected to make?

    Bristol-Myers Squibb costs less for the profit it is expected to make: 8.9× its forward earnings, against 17.6×.

  • BMY

    Which pays more in dividends?

    Bristol-Myers Squibb pays more back in dividends for what a share costs: 4.23% a year, against 2.42%.

  • Which do analysts rate higher?

    Analysts rate both the same: Buy.

  • ABBV

    Which is in the stronger price trend?

    AbbVie's price is in the stronger trend: 15.5% above its 200-day average, against 1.2% above.

What each company does

ABBVAbbVie

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.

Reports results on 3 February 2027

BMYBristol-Myers Squibb

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Reports results on 4 February 2027

This comparison is just the starting point.

Discover opportunities, understand companies and compare investments in one place. See how StratDeck works

Keep researching

Where next

Every US healthcare comparison

Free email

Up to speed in minutes, four times a week

Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.

Early access

Become a StratDeck founding user

Use StratDeck, tell us what's missing, and help decide what we build next.

100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.